Further, PDK1 inactivation effectively attenuated the development of Kras oncogene-driven pancreatic cancer, but not NSCLC, further supporting the importance of PDK1 in tumor development, albeit, in select cancer types [37]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.